|
시장보고서
상품코드
2112295
일회용 의료용 센서 시장 예측(-2031년) : 제품별, 유형별, 용도별, 최종사용자별, 지역별Disposable Medical Sensors Market by Product, Type, Application, And End User - Global Forecast to 2031 |
||||||
일회용 의료용 센서 시장 규모는 2026년 118억 6,000만 달러에서 2031년까지 161억 3,000만 달러에 달할 것으로 예측되고 있으며, 예측 기간 중 CAGR은 6.4%에 달할 전망입니다.
| 조사 범위 | |
|---|---|
| 조사 대상 기간 | 2026-2031년 |
| 기준연도 | 2025년 |
| 예측 기간 | 2026-2031년 |
| 산정 단위 | 금액(10억 달러) |
| 부문 | 제품별, 유형별, 용도별, 최종사용자별, 지역별 |
| 대상 지역 | 북미, 유럽, 아시아태평양, 라틴아메리카, 중동 및 아프리카 |
일회용 의료용 센서 시장은 주로 만성질환, 감염증, 생활습관병의 유병률 증가에 힘입어 성장하고 있으며, 이에 따라 정확하고 신속하며 지속적인 모니터링 솔루션에 대한 수요가 높아지고 있습니다. 환자 모니터링 시스템, 현장 진단(Point-of-Care), 웨어러블 의료기기, 재택 의료 솔루션의 도입이 확대됨에 따라 일회용 센서 기술에 대한 수요가 크게 증가하고 있습니다. 바이오센서, 웨어러블 센서,스트립 센서, 소형화된 모니터링 기기 등 일회용 센서 기술의 발전으로 진단 정확도, 신뢰성 및 사용 편의성이 향상되었습니다. 이러한 혁신을 통해 혈당 모니터링, 감염병 검사, 심전도 모니터링, 호흡 관리 및 기타 임상·재택 의료 분야에서 더욱 폭넓은 응용이 가능해졌습니다. 또한 감염 예방에 대한 중요성이 커지고, 교차 오염 위험이 줄어들며, 일회용 의료기기의 장점이 부각됨에 따라 의료 종사자들의 일회용 센서 도입이 촉진되고 있습니다.
또한 질병의 조기 발견, 원격 환자 모니터링, 그리고 맞춤형 의료 솔루션에 대한 환자와 의료 종사자의 인식 제고와 더불어, 의료 인프라 및 진단 시설의 확충도 시장 성장에 긍정적인 영향을 미치고 있습니다. 의료 수요의 증가, 기술의 진보, 그리고 디지털화 및 분산형 의료 솔루션의 채택 확대가 맞물려 일회용 의료용 센서에 대한 전 세계적 수요를 견인하고 있습니다.
"유형별로는 바이오센서가 일회용 의료용 센서 시장에서 가장 큰 시장 점유율을 차지했습니다."
유형별로는 일회용 의료용 센서 시장에서 바이오센서가 가장 큰 시장 점유율을 차지했습니다. 이러한 우위는 혈당 모니터링, 감염증 검사, 임신 검사, 약물·알코올 스크리닝, 그리고 연속 혈당 모니터링(CGM) 시스템 등 다양한 진단 및 모니터링 용도에서 바이오센서가 광범위하게 채택된 데 기인한 것으로 보입니다. 바이오센서는 생물학적 매개변수를 신속하고 정확하며 비침습적으로 검출하는 데 중요한 역할을 수행하고 있으며, 임상 현장과 재택 의료 모두에서 매우 높은 가치를 지니고 있습니다. 당뇨병, 감염증 및 기타 만성질환의 유병률 증가로 인해 바이오센서가 탑재된 일회용 의료기기에 대한 수요는 더욱 가속화되고 있습니다. 또한 감도 향상, 소형화, 디지털 헬스 플랫폼과의 통합 등 바이오센서 기술의 발전으로 편의성이 향상되어, 현장 진단(Point-of-Care) 및 원격 환자 모니터링 등 폭넓은 용도로 적용 범위가 확대되고 있습니다. 이러한 요인들이 일회용 의료용 센서 시장에서 바이오센서 부문이 주도적인 위치를 차지하는 한 가지 원인이 되고 있습니다.
"유형별로는 스트립 센서가 일회용 의료용 센서 시장에서 가장 큰 점유율을 차지할 것으로 예상됩니다."
유형별로는 스트립 센서가 일회용 의료용 센서 시장에서 가장 큰 점유율을 차지할 것으로 예상됩니다. 이러한 우위는 진단 용도, 특히 혈당 모니터링, 감염증 검사, 임신 검사 및 기타 신속한 현장 진단(Point-of-Care) 검사에서 널리 활용되고 있기 때문입니다. 스트립 센서는 합리적인 가격, 사용 편의성, 휴대성, 신속한 결과 확인, 최소한의 검체량 등 여러 가지 장점을 갖추고 있으며, 임상 현장과 재택 의료 환경 모두에 매우 적합합니다. 전 세계에서 당뇨병 및 감염증 유병률이 증가하고 있는 것이 혈당 측정 스트립 및 진단용 테스트 스트립의 수요 확대에 크게 기여하고 있습니다. 또한 자가 측정 기기, 분산형 진단 솔루션, 재택 의료 기술의 보급이 확대되고 있는 데다 센서의 정확도와 성능이 지속적으로 향상되고 있으며, 일회용 의료용 센서 시장에서 스트립 센서 부문의 성장과 주도적 입지가 향후 더욱 가속화될 것으로 예상됩니다.
"예측 기간 중 북미 일회용 의료용 센서 시장에서 미국은 가장 높은 연평균 성장률(CAGR)을 기록하며 성장할 것으로 전망됩니다."
예측 기간 중 북미 일회용 의료용 센서 시장에서 미국은 가장 높은 연평균 성장률(CAGR)을 기록하며 성장할 것으로 예상됩니다. 이러한 성장은 당뇨병, 심혈관 질환, 호흡기 질환 등 만성질환의 유병률 증가를 비롯한 몇 가지 주요 요인에 의해 주도되고 있으며, 이는 지속적인 모니터링 및 진단 솔루션에 대한 강력한 수요를 창출하고 있습니다. 미국의 첨단인 의료 인프라, 혁신적인 의료 기술의 높은 보급률, 그리고 주요 의료기기 제조업체들의 강력한 입지가 시장 확장을 더욱 지원하고 있습니다. 또한 웨어러블 의료기기, 원격 환자 모니터링 시스템, 현장 진단(Point-of-Care) 솔루션의 보급이 확대됨에 따라 병원, 진료소, 재택 의료 현장에서 일회용 센서에 대한 수요가 가속화되고 있습니다. 또한 감염 예방에 대한 의식의 향상, 일회용 의료기기의 장점, 그리고 유리한 보험 환급 정책이 맞물려 미국 시장에서 일회용 의료용 센서의 급속한 보급에 기여하고 있습니다. 이러한 요인들이 복합적으로 작용하여, 미국은 북미 일회용 의료용 센서 시장에서 가장 크고 가장 빠르게 성장하는 시장으로서의 입지를 확고히 하고 있습니다.
일회용 의료용 센서 시장에서 사업을 운영하는 주요 기업으로는 Abbott Laboratories(미국), F. Hoffmann-La Roche Ltd(스위스), Medtronic(아일랜드), 그리고 GE HealthCare Technologies Inc.(미국)가 있습니다.
조사 범위:
이 보고서는 일회용 의료용 센서 시장에 대한 분석을 제공하며, 제품, 용도, 유형, 최종사용자, 지역 등 각 부문별 시장 규모 및 향후 성장 잠재력 추정에 중점을 두고 있습니다. 또한 시장내 주요 기업의 경쟁 분석도 수록되어 있으며, 기업 개요, 제품 라인업, 최근 동향 및 주요 시장 전략 등이 포함되어 있습니다.
이 보고서를 구매해야 하는 이유
이 보고서는 일회용 의료용 센서 시장의 시장 선도 기업과 신규 진입 기업 모두에게 귀중한 인사이트를 제공하며, 가장 정확한 매출 추정치를 제시합니다. 이 보고서는 이해관계자가 경쟁 구도를 이해하고, 자사의 비즈니스를 더 나은 위치에 놓으며, 효과적인 시장 진입 전략을 수립하는 데 도움이 됩니다. 또한 이 보고서는 주요 시장 촉진요인, 억제요인, 과제 및 기회를 밝혀, 이해관계자가 현재의 시장 동향을 포괄적으로 이해할 수 있도록 지원합니다.
이 보고서는 다음 사항에 대한 인사이트를 제공합니다. :
- 주요 촉진요인(병원내 감염 및 오염에 대한 우려 증가, 대상 질환의 발병률 증가, 재택 의료기기에 대한 수요 확대, 일회용 의료용 센서 기술의 현저한 기술적 진보), 제약 요인(엄격한 규제 요건, 제품 검증 및 높은 규정 준수 비용, 환경 문제 및 일회용 의료 폐기물에 대한 규제 압력 증가),기회(신흥 경제국에서의 의료 인프라 확충 및 질병 부담 증가, 원격 환자 모니터링(RPM) 및 재택 의료의 확대), 그리고 과제(데이터 유출 측면에서 연결형 의료기기의 취약성)에 대한 인사이트를 제공합니다.
- 시장 침투도: 이 보고서에는 전 세계 일회용 의료기기 센서 시장의 주요 기업이 제공하는 제품에 대한 광범위한 정보가 포함되어 있습니다. 이 보고서에는 제품, 유형, 용도, 최종사용자, 지역 등 다양한 부문이 포함되어 있습니다.
- 제품 기능 강화 및 혁신: 전 세계 일회용 의료용 센서 시장에서 신제품 출시 및 예상되는 동향에 대한 포괄적인 세부 정보입니다.
- 시장 개발: 제품, 유형, 용도, 최종사용자, 지역별로 수익성이 높은 성장 시장에 대한 심층적인 인사이트와 분석을 제공합니다.
- 시장 다각화: 전 세계 일회용 의료용 센서 시장의 신제품 출시, 시장 확대, 현재 진행 상황 및 투자에 관한 포괄적인 정보입니다.
- 경쟁 분석: 전 세계 일회용 의료기기 센서 시장에서 주요 경쟁사의 시장 점유율, 성장 전략, 제품 라인업 및 역량에 대한 포괄적인 평가입니다.
자주 묻는 질문
목차
제1장 서론
제2장 개요
제3장 주요 인사이트
제4장 시장 개요
제5장 업계 동향
제6장 기술 진보, AI에 의한 영향, 특허, 혁신, 향후 응용
제7장 규제 상황과 지속가능성 구상
제8장 고객 상황과 구매 행동
제9장 일회용 의료용 센서 시장(제품별)
제10장 일회용 의료용 센서 시장(유형별)
제11장 일회용 의료용 센서 시장(용도별)
제12장 일회용 의료용 센서 시장(최종사용자별)
제13장 일회용 의료용 센서 시장(지역별)
제14장 경쟁 구도
제15장 기업 개요
제16장 조사 방법
제17장 부록
KSAThe disposable medical device sensors market is projected to reach USD 16.13 billion by 2031 from USD 11.86 billion in 2026, at a CAGR of 6.4% during the forecast period.
| Scope of the Report | |
|---|---|
| Years Considered for the Study | 2026-2031 |
| Base Year | 2025 |
| Forecast Period | 2026-2031 |
| Units Considered | Value (USD billion) |
| Segments | By product, type, application, end user, and region |
| Regions covered | North America, Europe, APAC, LATAM, MEA |
The disposable medical device sensors market is largely driven by the increasing prevalence of chronic diseases, infectious diseases, and lifestyle-related disorders, which has created a growing demand for accurate, rapid, and continuous monitoring solutions. The rising adoption of patient monitoring systems, point-of-care diagnostics, wearable healthcare devices, and home-based medical care solutions has significantly increased the demand for disposable sensor technologies. Advancements in disposable sensor technologies, including biosensors, wearable sensors, strip sensors, and miniaturized monitoring devices, have improved diagnostic accuracy, reliability, and ease of use. These innovations have enabled broader applications in glucose monitoring, infectious disease testing, cardiac monitoring, respiratory care, and other clinical and home healthcare settings. Furthermore, the growing emphasis on infection prevention, reduced risk of cross-contamination, and the advantages of single-use medical devices have strengthened the adoption of disposable sensors among healthcare providers.
Additionally, increasing awareness among patients and healthcare professionals regarding early disease detection, remote patient monitoring, and personalized healthcare solutions, along with the expansion of healthcare infrastructure and diagnostic facilities, has positively influenced market growth. The combination of rising healthcare needs, technological advancements, and increasing adoption of digital and decentralized healthcare solutions is driving the global demand for disposable medical device sensors.
"By type, biosensors held the largest market share in the disposable medical device sensors market."
By type, biosensors held the largest market share in the disposable medical device sensors market. This dominance can be attributed to the widespread adoption of biosensors across various diagnostic and monitoring applications, including glucose monitoring, infectious disease testing, pregnancy testing, drug and alcohol screening, and continuous glucose monitoring (CGM) systems. Biosensors play a critical role in enabling rapid, accurate, and minimally invasive detection of biological parameters, making them highly valuable in both clinical and home healthcare settings. The increasing prevalence of diabetes, infectious diseases, and other chronic conditions has further accelerated the demand for biosensor-based disposable medical devices. Additionally, advancements in biosensor technologies, including improved sensitivity, miniaturization, and integration with digital health platforms, have enhanced their usability and expanded their applications across point-of-care diagnostics and remote patient monitoring. These factors have contributed to the leading position of the biosensors segment in the disposable medical device sensors market.
"By type, strip sensors are expected to hold the largest share in the disposable medical device sensors market."
By type, strip sensors are expected to hold the largest share in the disposable medical device sensors market. This dominance is attributed to their extensive use in diagnostic applications, particularly glucose monitoring, infectious disease testing, pregnancy testing, and other rapid point-of-care testing procedures. Strip sensors offer several advantages, including affordability, ease of use, portability, quick turnaround time, and minimal sample requirements, making them highly suitable for both clinical and home-based healthcare settings. The increasing global prevalence of diabetes and infectious diseases has significantly contributed to the rising demand for glucose test strips and diagnostic test strips. Additionally, the growing adoption of self-monitoring devices, decentralized diagnostic solutions, and home healthcare technologies, along with continuous advancements in sensor accuracy and performance, is expected to further support the growth and leading position of the strip sensors segment in the disposable medical device sensors market.
"The US is expected to grow at the highest CAGR in the North American disposable medical device sensors market during the forecast period."
The US is expected to grow at the highest CAGR in the North American disposable medical device sensors market during the forecast period. This growth is driven by several key factors, including the increasing prevalence of chronic diseases such as diabetes, cardiovascular disorders, and respiratory conditions, which are creating a strong demand for continuous monitoring and diagnostic solutions. The country's advanced healthcare infrastructure, high adoption of innovative medical technologies, and strong presence of leading medical device manufacturers are further supporting market expansion. Additionally, the growing adoption of wearable medical devices, remote patient monitoring systems, and point-of-care diagnostic solutions is accelerating the demand for disposable sensors across hospitals, clinics, and home healthcare settings. Furthermore, increasing awareness regarding infection prevention, the benefits of single-use medical devices, and favorable reimbursement policies are contributing to the rapid adoption of disposable medical device sensors in the US market. Collectively, these factors position the US as the leading and fastest-growing market for disposable medical device sensors in North America.
A breakdown of the primary participants (on the supply side) for the disposable medical device sensors market referenced in this report is provided below:
- By Company Type: Tier 1 (35%), Tier 2 (40%), and Tier 3 (25%)
- By Designation: C-level Executives (45%), Directors (35%), and Others (20%)
- By Region: North America (27%), Europe (25%), Asia Pacific (30%), Latin America (8%), and the Middle East & Africa (10%)
The prominent players operating in the disposable medical device sensors market are Abbott Laboratories (US), F. Hoffmann-La Roche Ltd (Switzerland), Medtronic (Ireland), and GE HealthCare Technologies Inc. (US).
Research Coverage:
The report provides an analysis of the disposable medical device sensors market, focusing on estimating its size and future growth potential across segments such as product, application, type, end user, and region. Additionally, the report features a competitive analysis of key players in the market, including their company profiles, product offerings, recent developments, and key market strategies.
Reasons to Buy the Report
The report provides valuable insights for both market leaders and new entrants in the disposable medical device sensors market, offering the most accurate revenue estimates. It helps stakeholders understand the competitive landscape, enabling them to better position their businesses and develop effective go-to-market strategies. Additionally, the report highlights key market drivers, restraints, challenges, and opportunities, giving stakeholders a comprehensive understanding of current market trends.
This report provides insights into the following pointers:
- Analysis of key drivers (Rising concerns over hospital-acquired infections and contamination, Increasing incidence of target conditions, Growing demand for home-based medical care devices, Significant Technological Advancements in Disposable Medical Sensor Technologies), restraints (Stringent Regulatory Requirements, Product Validation, and High Compliance Costs, Environmental Concerns and Increasing Regulatory Pressure on Single-Use Medical Waste), opportunities (Expanding Healthcare Infrastructure and Rising Disease Burden in Emerging Economies, Expansion of Remote Patient Monitoring (RPM) and Home Healthcare), and challenges (Vulnerability of connected medical devices in terms of data leakages).
- Market Penetration: It includes extensive information on the products offered by the major players in the global disposable medical device sensors market. The report includes various segments, such as product, type, application, end user, and region.
- Product Enhancement/Innovation: Comprehensive details about new product launches and anticipated trends in the global disposable medical device sensors market.
- Market Development: Thorough knowledge and analysis of the profitable rising markets by product, type, application, end user, and region.
- Market Diversification: Comprehensive information about newly launched products, expanding markets, current advancements, and investments in the global disposable medical device sensors market.
- Competitive Assessment: A comprehensive assessment of market shares, growth strategies, product offerings, and capabilities of key competitors in the global disposable medical device sensors market.
TABLE OF CONTENTS
1 INTRODUCTION
- 1.1 STUDY OBJECTIVES
- 1.2 MARKET DEFINITION
- 1.3 STUDY SCOPE
- 1.3.1 MARKET SEGMENTATION AND REGIONS CONSIDERED
- 1.3.2 INCLUSIONS AND EXCLUSIONS
- 1.3.3 YEARS CONSIDERED
- 1.3.4 CURRENCY CONSIDERED
- 1.4 KEY STAKEHOLDERS
- 1.5 SUMMARY OF CHANGES
2 EXECUTIVE SUMMARY
- 2.1 KEY MARKET PARTICIPANTS: SHARE INSIGHTS AND DEVELOPMENTS
- 2.2 DISRUPTIVE TRENDS SHAPING MARKET
- 2.3 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS
- 2.4 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST
3 PREMIUM INSIGHTS
- 3.1 DISPOSABLE MEDICAL DEVICE SENSORS MARKET OVERVIEW
- 3.2 ASIA PACIFIC: DISPOSABLE MEDICAL DEVICE SENSORS MARKET, BY TYPE AND COUNTRY, (2025)
- 3.3 DISPOSABLE MEDICAL DEVICE SENSORS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
- 3.4 DISPOSABLE MEDICAL DEVICE SENSORS MARKET, REGIONAL MIX, 2024-2031
- 3.5 DISPOSABLE MEDICAL DEVICE SENSORS MARKET: EMERGING ECONOMIES VS. DEVELOPED MARKETS
4 MARKET OVERVIEW
- 4.1 INTRODUCTION
- 4.2 MARKET DYNAMICS
- 4.2.1 DRIVERS
- 4.2.1.1 Rising concerns over hospital-acquired infections and contamination
- 4.2.1.2 Increasing incidence of target conditions
- 4.2.1.3 Growing demand for home-based medical care devices
- 4.2.1.4 Advancements in sensor technologies
- 4.2.2 RESTRAINTS
- 4.2.2.1 Stringent regulatory requirements, product validation, and high compliance costs
- 4.2.2.2 Environmental concerns and increasing regulatory pressure on single-use medical waste
- 4.2.3 OPPORTUNITIES
- 4.2.3.1 Expanding healthcare infrastructure and rising disease burden in emerging economies
- 4.2.3.2 Expansion of remote patient monitoring and home healthcare
- 4.2.4 CHALLENGES
- 4.2.4.1 Vulnerability of connected medical devices in terms of data leakages
- 4.2.1 DRIVERS
- 4.3 UNMET NEEDS AND WHITE SPACES
- 4.3.1 UNMET NEEDS
- 4.3.2 WHITE SPACE OPPORTUNITIES
- 4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
- 4.4.1 INTERCONNECTED MARKETS
- 4.4.2 CROSS-SECTOR OPPORTUNITIES
- 4.5 STRATEGIC MOVES BY TIER- 1/2/3 PLAYERS
5 INDUSTRY TRENDS
- 5.1 PORTER'S FIVE FORCES ANALYSIS
- 5.1.1 THREAT OF NEW ENTRANTS
- 5.1.2 THREAT OF SUBSTITUTES
- 5.1.3 BARGAINING POWER OF SUPPLIERS
- 5.1.4 BARGAINING POWER OF BUYERS
- 5.1.5 INTENSITY OF COMPETITIVE RIVALRY
- 5.2 MACROECONOMIC OUTLOOK
- 5.2.1 INTRODUCTION
- 5.2.2 GDP TRENDS AND FORECAST
- 5.2.3 TRENDS IN DISPOSABLE MEDICAL DEVICE SENSORS MARKET
- 5.3 VALUE CHAIN ANALYSIS
- 5.4 ECOSYSTEM ANALYSIS
- 5.5 SUPPLY CHAIN ANALYSIS
- 5.6 PRICING ANALYSIS
- 5.6.1 AVERAGE SELLING PRICE, BY PRODUCT, 2023-2025
- 5.6.2 AVERAGE SELLING PRICE, BY REGION, 2023-2025
- 5.6.3 AVERAGE SELLING PRICE, BY KEY PLAYER, 2023-2025
- 5.7 TRADE ANALYSIS
- 5.7.1 IMPORT SCENARIO (HS CODE 901819)
- 5.7.2 EXPORT SCENARIO (HS CODE 901819)
- 5.8 KEY CONFERENCES & EVENTS DURING 2026-2027
- 5.9 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
- 5.10 INVESTMENT & FUNDING SCENARIO
- 5.11 CASE STUDY ANALYSIS
- 5.12 IMPACT OF US TARIFFS-DISPOSABLE MEDICAL DEVICE SENSORS MARKET
- 5.12.1 INTRODUCTION
- 5.12.2 KEY TARIFF RATES
- 5.12.3 PRICE IMPACT ANALYSIS
- 5.12.3.1 US
- 5.12.3.2 Europe
- 5.12.3.3 Asia Pacific
- 5.12.3.4 Impact on end-user industries
6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS
- 6.1 KEY EMERGING TECHNOLOGIES
- 6.1.1 AI-ENABLED WEARABLE BIOSENSORS & INTELLIGENT PATIENT MONITORING
- 6.1.2 FLEXIBLE ELECTRONICS & NEXT-GENERATION PRINTED BIOSENSORS
- 6.2 COMPLEMENTARY TECHNOLOGIES
- 6.2.1 INTERNET OF MEDICAL THINGS (IOMT) & REMOTE PATIENT MONITORING PLATFORMS
- 6.3 ADJACENT TECHNOLOGIES
- 6.3.1 MEMS & ADVANCED SEMICONDUCTOR TECHNOLOGIES
- 6.3.2 CLOUD COMPUTING, ARTIFICIAL INTELLIGENCE, AND DIGITAL HEALTH PLATFORMS
- 6.4 TECHNOLOGY/PRODUCT ROADMAP
- 6.4.1 SHORT-TERM |RECENT TECHNOLOGIES| FOUNDATION & EARLY COMMERCIALIZATION
- 6.4.2 MID-TERM (2027-2030) | EXPANSION & STANDARDIZATION
- 6.4.3 LONG-TERM (2030-2035+) | MASS COMMERCIALIZATION & DISRUPTION
- 6.5 PATENT ANALYSIS
- 6.5.1 PATENT PUBLICATION TRENDS FOR DISPOSABLE MEDICAL SENSORS
- 6.5.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
- 6.5.3 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR DISPOSABLE MEDICAL SENSORS PATENTS (JANUARY 2015-DECEMBER 2025)
- 6.5.4 TOP APPLICANT COUNTRIES/REGIONS PATENTS FOR DISPOSABLE MEDICAL SENSORS (JANUARY 2015-DECEMBER 2025)
- 6.6 IMPACT OF AI/GEN AI ON DISPOSABLE MEDICAL SENSORS MARKET
- 6.6.1 TOP USE CASES AND MARKET POTENTIAL
- 6.6.2 INTERCONNECTED ADJACENT ECOSYSTEMS AND IMPACT ON MARKET PLAYERS
- 6.6.3 CLIENTS' READINESS TO ADOPT GENERATIVE AI IN DISPOSABLE MEDICAL SENSORS MARKET
- 6.7 SUCCESS STORIES AND REAL-WORLD APPLICATIONS
- 6.7.1 ABBOTT: REVOLUTIONIZING CONTINUOUS GLUCOSE MONITORING WITH FREESTYLE LIBRE
- 6.7.2 DEXCOM: AI-ENABLED CONTINUOUS GLUCOSE MONITORING FOR PERSONALIZED DIABETES CARE
- 6.7.3 ICS COOL ENERGY: MASIMO REDUCES CROSS-CONTAMINATION AND IMPROVES INFECTION PREVENTION WITH LNCS SENSORS
7 REGULATORY LANDSCAPE AND SUSTAINABILITY INITIATIVES
- 7.1 REGIONAL REGULATIONS AND COMPLIANCE
- 7.1.1 US
- 7.1.2 EUROPEAN UNION
- 7.1.3 CHINA
- 7.1.4 LATIN AMERICA
- 7.1.5 MIDDLE EAST & AFRICA
- 7.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- 7.3 SUSTAINABILITY INITIATIVES
- 7.3.1 ENVIRONMENTAL SUSTAINABILITY IN DISPOSABLE MEDICAL SENSOR SYSTEMS
- 7.3.2 SUSTAINABLE MANUFACTURING & CIRCULAR ECONOMY INITIATIVES
- 7.3.3 DIGITAL HEALTH, REMOTE PATIENT MONITORING & SUSTAINABILITY
- 7.3.4 CERTIFICATIONS, LABELING, AND ECO-STANDARDS
8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR
- 8.1 DECISION-MAKING PROCESS
- 8.2 BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA
- 8.2.1 INFLUENCE OF KEY STAKEHOLDERS
- 8.2.2 BUYING CRITERIA
- 8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES
- 8.4 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
9 DISPOSABLE MEDICAL DEVICE SENSORS MARKET, BY PRODUCT
- 9.1 INTRODUCTION
- 9.2 BIOSENSORS
- 9.2.1 INCREASING NUMBER OF TARGET DISEASES AND RISING HEALTH AWARENESS TO PROPEL MARKET GROWTH
- 9.3 PRESSURE SENSORS
- 9.3.1 TECHNOLOGICAL ADVANCEMENTS IN PRESSURE SENSORS TO BOOST MARKET GROWTH
- 9.4 TEMPERATURE SENSORS
- 9.4.1 COST-EFFECTIVENESS OF TEMPERATURE SENSORS TO DRIVE DEMAND
- 9.5 ACCELEROMETERS
- 9.5.1 RISING GERIATRIC POPULATION TO SUPPORT MARKET GROWTH
- 9.6 IMAGE SENSORS
- 9.6.1 INNOVATIONS IN IMAGE SENSORS TO BOOST MARKET GROWTH
- 9.7 OTHER SENSORS
10 DISPOSABLE MEDICAL DEVICE SENSORS MARKET, BY TYPE
- 10.1 INTRODUCTION
- 10.2 STRIP SENSORS
- 10.2.1 RISING NUMBER OF DIABETIC PATIENTS TO SUPPORT MARKET GROWTH
- 10.3 WEARABLE SENSORS
- 10.3.1 TECHNOLOGICAL ADVANCEMENTS AND INNOVATIONS IN WEARABLE DEVICES TO BOOST MARKET GROWTH
- 10.4 INVASIVE SENSORS
- 10.4.1 INCREASED PREFERENCE FOR WEARABLE DEVICES MAY NEGATIVELY IMPACT MARKET FOR INVASIVE SENSORS
- 10.5 INGESTIBLE SENSORS
- 10.5.1 TECHNOLOGICAL ADVANCEMENTS IN INGESTIBLE SENSORS TO DRIVE END-USER DEMAND
11 DISPOSABLE MEDICAL DEVICE SENSORS MARKET, BY APPLICATION
- 11.1 INTRODUCTION
- 11.2 DIAGNOSTIC TESTING
- 11.2.1 BLOOD GLUCOSE TEST STRIP SENSORS
- 11.2.1.1 High prevalence of diabetes to drive market growth
- 11.2.2 PREGNANCY TEST STRIP SENSORS
- 11.2.2.1 Increasing demand for testing strips for home use to drive market growth
- 11.2.3 INFECTIOUS DISEASE TEST STRIP SENSORS
- 11.2.3.1 High burden of infectious diseases to propel market growth
- 11.2.4 DRUG & ALCOHOL TEST STRIP SENSORS
- 11.2.4.1 Market growth may be restrained as most tests are not available over the counter
- 11.2.1 BLOOD GLUCOSE TEST STRIP SENSORS
- 11.3 PATIENT MONITORING
- 11.3.1 CARDIAC MONITORS
- 11.3.1.1 Sedentary lifestyles causing an increase in cardiovascular disease prevalence-a key factor driving market growth
- 11.3.2 PULSE OXIMETERS
- 11.3.2.1 Growing need for continuous oxygen monitoring to boost demand for pulse oximeters
- 11.3.3 CONTINUOUS BLOOD PRESSURE MONITORS
- 11.3.3.1 Increasing prevalence of hypertension to drive market growth
- 11.3.4 CGM DEVICES
- 11.3.4.1 Increased preference for home-use devices to drive growth in this market segment
- 11.3.5 SMART PILLS
- 11.3.5.1 Ease of use and reduced expenditure associated with smart pills to drive market growth
- 11.3.6 OTHER PATIENT MONITORING DEVICES
- 11.3.1 CARDIAC MONITORS
- 11.4 THERAPEUTICS
- 11.4.1 DIALYSIS DEVICE SENSORS
- 11.4.1.1 Rising urology disorders to drive market growth
- 11.4.2 CARDIAC CATHETER SENSORS
- 11.4.2.1 High prevalence of cardiac diseases to boost market growth
- 11.4.3 INSULIN PUMP SENSORS
- 11.4.3.1 High cost of insulin pumps can limit market growth
- 11.4.1 DIALYSIS DEVICE SENSORS
- 11.5 IMAGING
- 11.5.1 CAPSULE ENDOSCOPE SENSORS
- 11.5.1.1 Capsule endoscopes are easy to use and cost-effective-key factors driving market growth
- 11.5.2 DISPOSABLE ENDOSCOPE SENSORS
- 11.5.2.1 Growing preference for single-use endoscopes and rising endoscopic procedures to drive market growth
- 11.5.1 CAPSULE ENDOSCOPE SENSORS
12 DISPOSABLE MEDICAL DEVICE SENSORS MARKET, BY END USER
- 12.1 INTRODUCTION
- 12.2 HOSPITALS & CLINICS
- 12.2.1 INCREASING PATIENT MONITORING NEEDS AND INFECTION CONTROL MEASURES SUPPORT THE MARKET GROWTH
- 12.3 HOME CARE SETTINGS
- 12.3.1 RISING ADOPTION OF REMOTE PATIENT MONITORING AND HOME-BASED HEALTHCARE TO BOOST THE MARKET GROWTH
- 12.4 DIAGNOSTIC LABS
- 12.4.1 GROWING DEMAND FOR ACCURATE DIAGNOSTICS AND POCT ACCELERATES ADOPTION
- 12.5 OTHER END USERS
13 DISPOSABLE MEDICAL DEVICE SENSORS MARKET, BY REGION
- 13.1 INTRODUCTION
- 13.2 NORTH AMERICA
- 13.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
- 13.2.2 US
- 13.2.2.1 Increasing funding and investments in medical sensors to drive market growth
- 13.2.3 CANADA
- 13.2.3.1 High prevalence of HAIs is a major factor driving the demand for disposable medical device sensors in Canada
- 13.3 EUROPE
- 13.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
- 13.3.2 GERMANY
- 13.3.2.1 Increasing demand for safer diagnostic devices to drive market growth in Germany
- 13.3.3 FRANCE
- 13.3.3.1 Growing geriatric population to increase demand for disposable medical device sensors
- 13.3.4 UK
- 13.3.4.1 Rising incidence of target diseases to support market growth
- 13.3.5 ITALY
- 13.3.5.1 Rising age-related disorders to aid market growth in Italy
- 13.3.6 SPAIN
- 13.3.6.1 Aging population and healthcare innovation to support market growth in Spain
- 13.3.7 REST OF EUROPE
- 13.4 ASIA PACIFIC
- 13.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
- 13.4.2 CHINA
- 13.4.2.1 Government initiatives to develop innovative healthcare products to propel market growth
- 13.4.3 JAPAN
- 13.4.3.1 High prevalence of HAIs to create demand for disposable medical device sensors
- 13.4.4 INDIA
- 13.4.4.1 High burden of chronic diseases to support market growth
- 13.4.5 AUSTRALIA
- 13.4.5.1 High burden of chronic diseases to support market growth
- 13.4.6 SOUTH KOREA
- 13.4.6.1 High burden of chronic diseases to support market growth
- 13.4.7 REST OF ASIA PACIFIC
- 13.5 LATIN AMERICA
- 13.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
- 13.5.2 BRAZIL
- 13.5.2.1 Growing healthcare burden and aging population to support market growth
- 13.5.3 MEXICO
- 13.5.3.1 Rising diabetes burden and healthcare demand to support market growth
- 13.5.4 REST OF LATIN AMERICA
- 13.6 MIDDLE EAST & AFRICA
- 13.6.1 HIGH PREVALENCE OF INFECTIOUS DISEASES TO BOOST MARKET GROWTH
- 13.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
- 13.7 GCC COUNTRIES
- 13.7.1 HEALTHCARE MODERNIZATION AND HIGH DIABETES BURDEN TO DRIVE THE MARKET GROWTH
- 13.7.2 MACROECONOMIC OUTLOOK FOR GCC COUNTRIES
14 COMPETITIVE LANDSCAPE
- 14.1 INTRODUCTION
- 14.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
- 14.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN DISPOSABLE MEDICAL DEVICE SENSORS MARKET
- 14.3 REVENUE ANALYSIS, 2021-2025
- 14.4 MARKET SHARE ANALYSIS (2025)
- 14.5 COMPANY VALUATION AND FINANCIAL METRICS
- 14.5.1 COMPANY VALUATION
- 14.5.2 FINANCIAL METRICS
- 14.5.3 BRAND/PRODUCT COMPARISON
- 14.6 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
- 14.6.1 STARS
- 14.6.2 EMERGING LEADERS
- 14.6.3 PERVASIVE PLAYERS
- 14.6.4 PARTICIPANTS
- 14.6.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025
- 14.6.5.1 Company footprint
- 14.6.5.2 Region footprint
- 14.6.5.3 Type footprint
- 14.6.5.4 Application footprint
- 14.6.5.5 Product footprint
- 14.6.5.6 End-user footprint
- 14.7 COMPANY EVALUATION MATRIX: STARTUPS/SMES (2025)
- 14.7.1 PROGRESSIVE COMPANIES
- 14.7.2 RESPONSIVE COMPANIES
- 14.7.3 DYNAMIC COMPANIES
- 14.7.4 STARTING BLOCKS
- 14.7.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025
- 14.7.5.1 Detailed list of key startups/SMEs
- 14.7.5.2 Competitive benchmarking of key startups/SMEs
- 14.8 R&D EXPENDITURE OF KEY PLAYERS (DISPOSABLE MEDICAL DEVICE SENSORS MARKET)
- 14.9 COMPETITIVE SCENARIO
- 14.9.1 PRODUCT LAUNCHES & APPROVALS
- 14.9.2 DEALS
- 14.9.3 EXPANSIONS
15 COMPANY PROFILES
- 15.1 INTRODUCTION
- 15.2 KEY PLAYERS
- 15.2.1 ABBOTT LABORATORIES
- 15.2.1.1 Business overview
- 15.2.1.2 Products offered
- 15.2.1.3 Recent developments
- 15.2.1.3.1 Product approvals
- 15.2.1.3.2 Deals
- 15.2.1.3.3 Expansions
- 15.2.1.3.4 Other developments
- 15.2.1.4 MnM view
- 15.2.1.4.1 Right to win
- 15.2.1.4.2 Strategic choices made
- 15.2.1.4.3 Weaknesses and competitive threats
- 15.2.2 F. HOFFMANN-LA ROCHE LTD.
- 15.2.2.1 Business overview
- 15.2.2.2 Products offered
- 15.2.2.3 Recent developments
- 15.2.2.3.1 Product launches & approvals
- 15.2.2.3.2 Deals
- 15.2.2.3.3 Expansions
- 15.2.2.4 MnM view
- 15.2.2.4.1 Right to win
- 15.2.2.4.2 Strategic choices made
- 15.2.2.4.3 Weaknesses and competitive threats
- 15.2.3 MEDTRONIC PLC
- 15.2.3.1 Business Overview
- 15.2.3.2 Products offered
- 15.2.3.3 Recent developments
- 15.2.3.3.1 Product launches & approvals
- 15.2.3.3.2 Deals
- 15.2.3.3.3 Expansions
- 15.2.3.4 MnM view
- 15.2.3.4.1 Right to win
- 15.2.3.4.2 Strategic choices made
- 15.2.3.4.3 Weaknesses and competitive threats
- 15.2.4 LIFESCAN IP HOLDINGS, LLC
- 15.2.4.1 Business overview
- 15.2.4.2 Products offered
- 15.2.4.3 Recent developments
- 15.2.4.3.1 Deals
- 15.2.4.4 MnM view
- 15.2.4.4.1 Right to win
- 15.2.4.4.2 Strategic choices made
- 15.2.4.4.3 Weaknesses and competitive threats
- 15.2.5 TEXAS INSTRUMENTS
- 15.2.5.1 Business overview
- 15.2.5.2 Products offered
- 15.2.5.3 Recent developments
- 15.2.5.3.1 Expansions
- 15.2.5.4 MnM view
- 15.2.5.4.1 Right to win
- 15.2.5.4.2 Strategic choices made
- 15.2.5.4.3 Weaknesses and competitive threats
- 15.2.6 TE CONNECTIVITY
- 15.2.6.1 Business overview
- 15.2.6.2 Products offered
- 15.2.6.3 Recent developments
- 15.2.6.3.1 Product launches
- 15.2.6.3.2 Deals
- 15.2.6.3.3 Expansions
- 15.2.7 HONEYWELL INTERNATIONAL, INC.
- 15.2.7.1 Business overview
- 15.2.7.2 Products offered
- 15.2.7.3 Recent developments
- 15.2.7.3.1 Product launches
- 15.2.7.3.2 Deals
- 15.2.8 NXP SEMICONDUCTORS N.V.
- 15.2.8.1 Business overview
- 15.2.8.2 Products offered
- 15.2.9 STMICROELECTRONICS N.V.
- 15.2.9.1 Business overview
- 15.2.9.2 Products offered
- 15.2.9.3 Recent developments
- 15.2.9.3.1 Product launches
- 15.2.9.3.2 Deals
- 15.2.10 ANALOG DEVICES, INC.
- 15.2.10.1 Business overview
- 15.2.10.2 Products offered
- 15.2.11 ICU MEDICAL, INC. (SMITHS MEDICAL)
- 15.2.11.1 Business overview
- 15.2.11.2 Products offered
- 15.2.11.3 Recent developments
- 15.2.11.3.1 Deals
- 15.2.12 KONINKLIJKE PHILIPS N.V.
- 15.2.12.1 Business overview
- 15.2.12.2 Products offered
- 15.2.12.3 Recent developments
- 15.2.12.3.1 Deals
- 15.2.12.3.2 Expansions
- 15.2.13 GE HEALTHCARE
- 15.2.13.1 Business overview
- 15.2.13.2 Products offered
- 15.2.14 OMNIVISION
- 15.2.14.1 Business overview
- 15.2.14.2 Products offered
- 15.2.14.3 Recent developments
- 15.2.14.3.1 Product launches
- 15.2.15 LIFESIGNALS
- 15.2.15.1 Business overview
- 15.2.15.2 Products offered
- 15.2.15.3 Recent developments
- 15.2.15.3.1 Product approvals
- 15.2.1 ABBOTT LABORATORIES
- 15.3 OTHER PLAYERS
- 15.3.1 SENSIRION AG
- 15.3.2 AMPHENOL CORPORATION
- 15.3.3 NUOVA GMBH
- 15.3.4 STARBOARD MEDICAL, INC.
- 15.3.5 SHENZHEN MED-LINK ELECTRONICS TECH CO., LTD.
- 15.3.6 MEDICAL SENSORS INDIA PVT. LTD.
- 15.3.7 GENTAG, INC.
- 15.3.8 VITALCONNECT, INC.
- 15.3.9 CONMED CORPORATION
- 15.3.10 SSI ELECTRONICS
16 RESEARCH METHODOLOGY
- 16.1 RESEARCH DATA
- 16.1.1 SECONDARY DATA
- 16.1.1.1 Key data from secondary sources
- 16.1.2 PRIMARY DATA
- 16.1.2.1 Key data from primary sources
- 16.1.2.2 Key industry insights
- 16.1.1 SECONDARY DATA
- 16.2 MARKET SIZE ESTIMATION
- 16.3 MARKET BREAKDOWN AND DATA TRIANGULATION
- 16.4 MARKET SHARE ESTIMATION
- 16.5 RESEARCH ASSUMPTIONS
- 16.6 RESEARCH LIMITATIONS
- 16.6.1 SCOPE-RELATED LIMITATIONS
- 16.6.2 METHODOLOGY-RELATED LIMITATIONS
- 16.7 RISK ASSESSMENT
17 APPENDIX
- 17.1 DISCUSSION GUIDE
- 17.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
- 17.3 CUSTOMIZATION OPTIONS
- 17.4 RELATED REPORTS
- 17.5 AUTHOR DETAILS
